Cargando…

Kidney Disease in HIV Infection

Antiretroviral therapy (ART) has significantly improved life expectancy of infected subjects, generating a new epidemiological setting of people aging withHuman Immunodeficiency Virus (HIV). People living with HIV (PLWH), having longer life expectancy, now face several age-related conditions as well...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alfano, Gaetano, Cappelli, Gianni, Fontana, Francesco, Di Lullo, Luca, Di Iorio, Biagio, Bellasi, Antonio, Guaraldi, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722524/ https://www.ncbi.nlm.nih.gov/pubmed/31430930 http://dx.doi.org/10.3390/jcm8081254

Ejemplares similares

Chronic Kidney Disease: The Silent Epidemy
por: Bellasi, Antonio, et al.
Publicado: (2019)

Very Low Protein Diet for Patients with Chronic Kidney Disease: Recent Insights
por: Di Micco, Lucia, et al.
Publicado: (2019)

Peritoneal dialysis in the time of coronavirus disease 2019
por: Alfano, Gaetano, et al.
Publicado: (2020)

Correction of metabolic acidosis improves insulin resistance in chronic kidney disease
por: Bellasi, Antonio, et al.
Publicado: (2016)

Phosphate Metabolism Modulation in Chronic Kidney Disease: When, How and to What Extent?
por: Bellasi, Antonio, et al.
Publicado: (2014)

Thromboembolic and Bleeding Risk in Atrial Fibrillation Patients with Chronic Kidney Disease: Role of Anticoagulation Therapy
por: Magnocavallo, Michele, et al.
Publicado: (2020)

One‐year persistence of neutralizing anti‐SARS‐CoV‐2 antibodies in dialysis patients recovered from COVID‐19
por: Alfano, Gaetano, et al.
Publicado: (2021)

Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI Study
por: Di Iorio, Biagio R., et al.
Publicado: (2019)

Correction to: Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI Study
por: Di Iorio, Biagio R., et al.
Publicado: (2020)

Fractional Excretion of Phosphate (FeP) Is Associated with End-Stage Renal Disease Patients with CKD 3b and 5
por: Bellasi, Antonio, et al.
Publicado: (2019)

Rethinking Chronic Kidney Disease in the Aging Population
por: Alfano, Gaetano, et al.
Publicado: (2022)

Seroconversion after COVID-19 vaccine in a dialysis patient on immunosuppressants
por: Alfano, Gaetano, et al.
Publicado: (2021)

Which criteria should we use to end isolation in hemodialysis patients with COVID-19?
por: Alfano, Gaetano, et al.
Publicado: (2022)

Clinical Predictors of Nondiabetic Kidney Disease in Patients with Diabetes: A Single-Center Study
por: Fontana, Francesco, et al.
Publicado: (2021)

Mineral and Electrolyte Disorders With SGLT2i Therapy
por: Cianciolo, Giuseppe, et al.
Publicado: (2019)

QT interval in CKD and haemodialysis patients
por: Di Iorio, Biagio, et al.
Publicado: (2013)

Vascular Calcification Progression Modulates the Risk Associated with Vascular Calcification Burden in Incident to Dialysis Patients
por: Bellasi, Antonio, et al.
Publicado: (2021)

The frail world of haemodialysis patients in the COVID-19 pandemic era: a systematic scoping review
por: Alfano, Gaetano, et al.
Publicado: (2021)

Treatment of secondary hyperparathyroidism: the clinical utility of etelcalcetide
por: Cozzolino, Mario, et al.
Publicado: (2017)

Predictive Value of Measures of Vascular Calcification Burden and Progression for Risk of Death in Incident to Dialysis Patients
por: Bellasi, Antonio, et al.
Publicado: (2021)

Fibroblast growth factor 23 and parathyroid hormone predict extent of aortic valve calcifications in patients with mild to moderate chronic kidney disease
por: Di Lullo, Luca, et al.
Publicado: (2015)

Finerenone: Questions and Answers—The Four Fundamental Arguments on the New-Born Promising Non-Steroidal Mineralocorticoid Receptor Antagonist
por: Di Lullo, Luca, et al.
Publicado: (2023)

Prevalence, clinical course and outcomes of COVID-19 in peritoneal dialysis (PD) patients: a single-center experience
por: Alfano, Gaetano, et al.
Publicado: (2022)

Pathophysiology of the cardio-renal syndromes types 1–5: An uptodate
por: Di Lullo, L., et al.
Publicado: (2017)

Clinical Presentation, Renal Histopathological Findings, and Outcome in Patients with Monoclonal Gammopathy and Kidney Disease
por: Alfano, Gaetano, et al.
Publicado: (2021)

SARS-CoV-2 infection in dialysis patients in northern Italy: a single-centre experience
por: Fontana, Francesco, et al.
Publicado: (2020)

SARS-CoV-2 infection in dialysis patients in northern Italy: a single-centre experience
por: Fontana, Francesco, et al.
Publicado: (2020)

Methicillin-Resistant Staphylococcus aureus Peritonitis due to Hematogenous Dissemination from Central Venous Catheter in a Maintenance Dialysis Patient
por: Alfano, Gaetano, et al.
Publicado: (2021)

Acute pancreatitis associated with everolimus after kidney transplantation: a case report
por: Fontana, Francesco, et al.
Publicado: (2016)

Clinical Utility of Epstein-Barr Virus Viral Load Monitoring and Risk Factors for Posttransplant Lymphoproliferative Disorders After Kidney Transplantation: A Single-Center, 10-Year Observational Cohort Study
por: Franceschini, Erica, et al.
Publicado: (2017)

Ethical challenges in managing unvaccinated patients receiving chronic in-centre haemodialysis
por: Alfano, Gaetano, et al.
Publicado: (2021)

Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients
por: Alfano, Gaetano, et al.
Publicado: (2021)

Influence of dialysate temperature on creatinine peritoneal clearance in peritoneal dialysis patients: a randomized trial
por: Fontana, Francesco, et al.
Publicado: (2020)

Diagnostic Workup for Disorders of Bone and Mineral Metabolism in Patients with Chronic Kidney Disease in the Era of KDIGO Guidelines
por: Morrone, Luigi Francesco, et al.
Publicado: (2011)

Incidence, risk factors and outcome of acute kidney injury (AKI) in patients with COVID-19
por: Alfano, Gaetano, et al.
Publicado: (2021)

Acid base disorders in patients with COVID-19
por: Alfano, Gaetano, et al.
Publicado: (2021)

Nutritional Therapy Modulates Intestinal Microbiota and Reduces Serum Levels of Total and Free Indoxyl Sulfate and P-Cresyl Sulfate in Chronic Kidney Disease (Medika Study)
por: Di Iorio, Biagio Raffaele, et al.
Publicado: (2019)

The “FIFTY SHADOWS” of the RALES Trial: Lessons about the Potential Risk of Dietary Potassium Supplementation in Patients with Chronic Kidney Disease
por: Romero-González, Gregorio, et al.
Publicado: (2022)

New Challenges in Heart Failure with Reduced Ejection Fraction: Managing Worsening Events
por: Lavalle, Carlo, et al.
Publicado: (2023)

Arterial Stiffness in Chronic Kidney Disease: The Usefulness of a Marker of Vascular Damage
por: Bellasi, Antonio, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_eu7issu3spriisfl1n25n7nek4